The Yin and Yang of HLA and KIR in human disease

Seminars in Immunology

Volumn 20, Issue 6, 2008, Pages 343-352

  Kulkarni, Smita ^a   Martin, Maureen P ^b   Carrington, Mary ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

Disease associations; HLA; KIR; Natural killer cells

Indexed keywords

HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LIGAND;

AUTOIMMUNE DISEASE; DISEASE ASSOCIATION; GENE EXPRESSION; GENE INTERACTION; GENE LOCUS; GENE SEGREGATION; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS C VIRUS; HERPES VIRUS; HLA SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATORY DISEASE; MULTIFACTORIAL INHERITANCE; NATURAL KILLER CELL; NEOPLASM; REPRODUCTION; REVIEW; T LYMPHOCYTE; VIRUS INFECTION;

AUTOIMMUNITY; DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INFLAMMATION; KILLER CELLS, NATURAL; NEOPLASMS; RECEPTORS, KIR; REPRODUCTION; VIRUS DISEASES; YIN-YANG;

EID: 56549090945     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.smim.2008.06.003     Document Type: Review

References (125)

1. Khakoo S.I., Rajalingam R., Shum B.P., Weidenbach K., Flodin L., Muir D.G., et al. Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity 12 6 (2000) 687-698
2. Khakoo S.I., and Carrington M. KIR and disease: a model system or system of models?. Immunol Rev 214 (2006) 186-201
3. Single R.M., Martin M.P., Gao X., Meyer D., Yeager M., Kidd J.R., et al. Global diversity and evidence for coevolution of KIR and HLA. Nat Genet 39 9 (2007) 1114-1119
4. Norman P.J., Abi-Rached L., Gendzekhadze K., Korbel D., Gleimer M., Rowley D., et al. Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans. Nat Genet 39 9 (2007) 1092-1099
5. Karre K., Ljunggren H.G., Piontek G., and Kiessling R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature 319 6055 (1986) 675-678
6. Hoglund P., Ohlen C., Carbone E., Franksson L., Ljunggren H.G., Latour A., et al. Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m-mice: nonresponsiveness controlled by beta 2m-bone marrow in chimeric mice. Proc Natl Acad Sci USA 88 22 (1991) 10332-10336
7. Ljunggren H.G., and Karre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11 7 (1990) 237-244
8. Liao N.S., Bix M., Zijlstra M., Jaenisch R., and Raulet D. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253 5016 (1991) 199-202
9. Diefenbach A., and Raulet D.H. Strategies for target cell recognition by natural killer cells. Immunol Rev 181 (2001) 170-184
10. Lanier L.L. NK cell recognition. Annu Rev Immunol 23 (2005) 225-274
11. Arase H., Mocarski E.S., Campbell A.E., Hill A.B., and Lanier L.L. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296 5571 (2002) 1323-1326
12. Hoelsbrekken S.E., Nylenna O., Saether P.C., Slettedal I.O., Ryan J.C., Fossum S., et al. Cutting edge: molecular cloning of a killer cell Ig-like receptor in the mouse and rat. J Immunol 170 5 (2003) 2259-2263
13. Mager D.L., McQueen K.L., Wee V., and Freeman J.D. Evolution of natural killer cell receptors: coexistence of functional Ly49 and KIR genes in baboons. Curr Biol 11 8 (2001) 626-630
14. Westgaard I.H., Berg S.F., Orstavik S., Fossum S., and Dissen E. Identification of a human member of the Ly-49 multigene family. Eur J Immunol 28 6 (1998) 1839-1846
15. Carrington M., and Norman P.J. The KIR gene cluster (2003), U.S. National Library Med., National Centre for Biotechnology Information, Bethesda, MD
16. Sambrook J.G., Bashirova A., Andersen H., Piatak M., Vernikos G.S., Coggill P., et al. Identification of the ancestral killer immunoglobulin-like receptor gene in primates. BMC Genomics 7 (2006) 209
17. Guethlein L.A., Abi-Rached L., Hammond J.A., and Parham P. The expanded cattle KIR genes are orthologous to the conserved single-copy KIR3DX1 gene of primates. Immunogenetics 59 6 (2007) 517-522
18. Martin A.M., Kulski J.K., Gaudieri S., Witt C.S., Freitas E.M., Trowsdale J., et al. Comparative genomic analysis, diversity and evolution of two KIR haplotypes A and B. Gene 335 (2004) 121-131
19. Martin M.P., Bashirova A., Traherne J., Trowsdale J., and Carrington M. Cutting edge: expansion of the KIR locus by unequal crossing over. J Immunol 171 5 (2003) 2192-2195
20. Kikuchi-Maki A., Catina T.L., and Campbell K.S. Cutting edge: KIR2DL4 transduces signals into human NK cells through association with the Fc receptor gamma protein. J Immunol 174 7 (2005) 3859-3863
21. Hsu K.C., Liu X.R., Selvakumar A., Mickelson E., O'Reilly R.J., and Dupont B. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J Immunol 169 9 (2002) 5118-5129
22. Witt C.S., Martin A., and Christiansen F.T. Detection of KIR2DL4 alleles by sequencing and SSCP reveals a common allele with a shortened cytoplasmic tail. Tissue Antigens 56 3 (2000) 248-257
23. Winter C.C., and Long E.O. A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J Immunol 158 9 (1997) 4026-4028
24. Moesta A.K., Norman P.J., Yawata M., Yawata N., Gleimer M., and Parham P. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C Than KIR2DL3. J Immunol 180 6 (2008) 3969-3979
25. Cella M., Longo A., Ferrara G.B., Strominger J.L., and Colonna M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J Exp Med 180 4 (1994) 1235-1242
26. Gumperz J.E., Litwin V., Phillips J.H., Lanier L.L., and Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 181 3 (1995) 1133-1144
27. Carr W.H., Pando M.J., and Parham P. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J Immunol 175 8 (2005) 5222-5229
28. Gumperz J.E., Barber L.D., Valiante N.M., Percival L., Phillips J.H., Lanier L.L., et al. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor. J Immunol 158 11 (1997) 5237-5241
29. Luque I., Solana R., Galiani M.D., Gonzalez R., Garcia F., Lopez de Castro J.A., et al. Threonine 80 on HLA-B27 confers protection against lysis by a group of natural killer clones. Eur J Immunol 26 8 (1996) 1974-1977
30. Rajagopalan S., and Long E.O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J Exp Med 189 7 (1999) 1093-1100
31. Dohring C., Scheidegger D., Samaridis J., Cella M., and Colonna M. A human killer inhibitory receptor specific for HLA-A1,2. J Immunol 156 9 (1996) 3098-3101
32. Biassoni R., Pessino A., Malaspina A., Cantoni C., Bottino C., Sivori S., et al. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur J Immunol 27 12 (1997) 3095-3099
33. Stewart C.A., Laugier-Anfossi F., Vely F., Saulquin X., Riedmuller J., Tisserant A., et al. Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. Proc Natl Acad Sci USA 102 37 (2005) 13224-13229
34. Foley B., De Santis D., Lathbury L., Christiansen F., and Witt C. KIR2DS1-mediated activation overrides NKG2A-mediated inhibition in HLA-C C2-negative individuals. Int Immunol 20 4 (2008) 555-563
35. Chewning J.H., Gudme C.N., Hsu K.C., Selvakumar A., and Dupont B. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. J Immunol 179 2 (2007) 854-868
36. Trundley A., Frebel H., Jones D., Chang C., and Trowsdale J. Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies. Eur J Immunol 37 3 (2007) 780-787
37. Carr W.H., Rosen D.B., Arase H., Nixon D.F., Michaelsson J., and Lanier L.L. Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J Immunol 178 2 (2007) 647-651
38. Pascal V., Yamada E., Martin M.P., Alter G., Altfeld M., Metcalf J.A., et al. Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection. J Immunol 179 3 (2007) 1625-1633
39. O'Connor G.M., Guinan K.J., Cunningham R.T., Middleton D., Parham P., and Gardiner C.M. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J Immunol 178 1 (2007) 235-241
40. Martin M.P., Gao X., Lee J.H., Nelson G.W., Detels R., Goedert J.J., et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 31 4 (2002) 429-434
41. Qi Y., Martin M.P., Gao X., Jacobson L., Goedert J.J., Buchbinder S., et al. KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog 2 8 (2006) e79
42. Alter G., Martin M.P., Teigen N., Carr W.H., Suscovich T.J., Schneidewind A., et al. Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 204 12 (2007) 3027-3036
43. Katz G., Markel G., Mizrahi S., Arnon T.I., and Mandelboim O. Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell receptor killer cell Ig-like receptor two-domain short tail number 4. J Immunol 166 12 (2001) 7260-7267
44. Katz G., Gazit R., Arnon T.I., Gonen-Gross T., Tarcic G., Markel G., et al. MHC class I-independent recognition of NK-activating receptor KIR2DS4. J Immunol 173 3 (2004) 1819-1825
45. Valiante N.M., Uhrberg M., Shilling H.G., Lienert-Weidenbach K., Arnett K.L., D'Andrea A., et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7 6 (1997) 739-751
46. Chan H.W., Miller J.S., Moore M.B., and Lutz C.T. Epigenetic control of highly homologous killer Ig-like receptor gene alleles. J Immunol 175 9 (2005) 5966-5974
47. Davies G.E., Locke S.M., Wright P.W., Li H., Hanson R.J., Miller J.S., et al. Identification of bidirectional promoters in the human KIR genes. Genes Immun 8 3 (2007) 245-253
48. Winter C.C., Gumperz J.E., Parham P., Long E.O., and Wagtmann N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J Immunol 161 2 (1998) 571-577
49. Ahlenstiel G., Martin M.P., Gao X., Carrington M., and Rehermann B. Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest 118 3 (2008) 1017-1026
50. Gardiner C.M., Guethlein L.A., Shilling H.G., Pando M., Carr W.H., Rajalingam R., et al. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 gene polymorphism. J Immunol 166 5 (2001) 2992-3001
51. Yawata M., Yawata N., Draghi M., Little A.M., Partheniou F., and Parham P. Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J Exp Med 203 3 (2006) 633-645
52. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5 3 (2005) 201-214
53. Malnati M.S., Peruzzi M., Parker K.C., Biddison W.E., Ciccone E., Moretta A., et al. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267 5200 (1995) 1016-1018
54. Rajagopalan S., and Long E.O. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J Exp Med 185 8 (1997) 1523-1528
55. Zappacosta F., Borrego F., Brooks A.G., Parker K.C., and Coligan J.E. Peptides isolated from HLA-Cw*0304 confer different degrees of protection from natural killer cell-mediated lysis. Proc Natl Acad Sci USA 94 12 (1997) 6313-6318
56. Boyington J.C., Motyka S.A., Schuck P., Brooks A.G., and Sun P.D. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405 6786 (2000) 537-543
57. Hansasuta P., Dong T., Thananchai H., Weekes M., Willberg C., Aldemir H., et al. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur J Immunol 34 6 (2004) 1673-1679
58. Thananchai H., Gillespie G., Martin M.P., Bashirova A., Yawata N., Yawata M., et al. Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol 178 1 (2007) 33-37
59. Raulet D.H., Held W., Correa I., Dorfman J.R., Wu M.F., and Corral L. Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors. Immunol Rev 155 (1997) 41-52
60. Kim S., Poursine-Laurent J., Truscott S.M., Lybarger L., Song Y.J., Yang L., et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436 7051 (2005) 709-713
61. Fernandez N.C., Treiner E., Vance R.E., Jamieson A.M., Lemieux S., and Raulet D.H. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105 11 (2005) 4416-4423
62. Anfossi N., Andre P., Guia S., Falk C.S., Roetynck S., Stewart C.A., et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25 2 (2006) 331-342
63. Kim S., Sunwoo J.B., Yang L., Choi T., Song Y.J., French A.R., et al. HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci USA 105 8 (2008) 3053-3058
64. Long B.R., Ndhlovu L.C., Oksenberg J.R., Lanier L.L., Hecht F.M., Nixon D.F., et al. Conferral of enhanced natural killer cell function by KIR3DS1 in early HIV1 infection. J Virol 82 10 (2008) 4785-4792
65. Ravet S., Scott-Algara D., Bonnet E., Tran H.K., Tran T., Nguyen N., et al. Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood 109 10 (2007) 4296-4305
66. Boulet S., Sharafi S., Simic N., Bruneau J., Routy J.P., Tsoukas C.M., et al. Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. Aids 22 5 (2008) 595-599
67. Jennes W., Verheyden S., Demanet C., Adje-Toure C.A., Vuylsteke B., Nkengasong J.N., et al. Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J Immunol 177 10 (2006) 6588-6592
68. Pando M.J., Gardiner C.M., Gleimer M., McQueen K.L., and Parham P. The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J Immunol 171 12 (2003) 6640-6649
69. Martin M.P., Qi Y., Gao X., Yamada E., Martin J.N., Pereyra F., et al. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 39 6 (2007) 733-740
70. Cooley S., Xiao F., Pitt M., Gleason M., McCullar V., Bergemann T.L., et al. A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature. Blood 110 2 (2007) 578-586
71. Khakoo S.I., Thio C.L., Martin M.P., Brooks C.R., Gao X., Astemborski J., et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305 5685 (2004) 872-874
72. Romero V., Azocar J., Zuniga J., Clavijo O.P., Terreros D., Gu X., et al. Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome. Mol Immunol 45 9 (2008) 2429-2436
73. Biron C.A., Byron K.S., and Sullivan J.L. Severe herpesvirus infections in an adolescent without natural killer cells. N Engl J Med 320 26 (1989) 1731-1735
74. Lin A., Xu H., and Yan W. Modulation of HLA expression in human cytomegalovirus immune evasion. Cell Mol Immunol 4 2 (2007) 91-98
75. Gazit R., Garty B.Z., Monselise Y., Hoffer V., Finkelstein Y., Markel G., et al. Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. Blood 103 5 (2004) 1965-1966
76. Cook M., Briggs D., Craddock C., Mahendra P., Milligan D., Fegan C., et al. Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood 107 3 (2006) 1230-1232
77. Price P., Witt C., de Santis D., and French M.A. Killer immunoglobulin-like receptor genotype may distinguish immunodeficient HIV-infected patients resistant to immune restoration diseases associated with herpes virus infections. J Acquir Immune Defic Syndr 45 3 (2007) 359-361
78. Mendez A., Granda H., Meenagh A., Contreras S., Zavaleta R., Mendoza M.F., et al. Study of KIR genes in tuberculosis patients. Tissue Antigens 68 5 (2006) 386-389
79. D'Ombrain M.C., Voss T.S., Maier A.G., Pearce J.A., Hansen D.S., Cowman A.F., et al. Plasmodium falciparum erythrocyte membrane protein-1 specifically suppresses early production of host interferon-gamma. Cell Host Microbe 2 2 (2007) 130-138
80. Mavoungou E., Held J., Mewono L., and Kremsner P.G. A Duffy binding-like domain is involved in the NKp30-mediated recognition of Plasmodium falciparum-parasitized erythrocytes by natural killer cells. J Infect Dis 195 10 (2007) 1521-1531
81. Hansen D.S., D'Ombrain M.C., and Schofield L. The role of leukocytes bearing natural killer complex receptors and killer immunoglobulin-like receptors in the immunology of malaria. Curr Opin Immunol 19 4 (2007) 416-423
82. Artavanis-Tsakonas K., Eleme K., McQueen K.L., Cheng N.W., Parham P., Davis D.M., et al. Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes. J Immunol 171 10 (2003) 5396-5405
83. Roetynck S., Baratin M., Johansson S., Lemmers C., Vivier E., and Ugolini S. Natural killer cells and malaria. Immunol Rev 214 (2006) 251-263
84. Abi-Rached L., and Parham P. Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J Exp Med 201 8 (2005) 1319-1332
85. Hou L., Steiner N.K., Chen M., Belle I., Kubit A.L., Ng J., et al. Limited allelic diversity of stimulatory two-domain killer cell immunoglobulin-like receptors. Hum Immunol 69 3 (2008) 174-178
86. Namekawa T., Snyder M.R., Yen J.H., Goehring B.E., Leibson P.J., Weyand C.M., et al. Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol 165 2 (2000) 1138-1145
87. Yen J.H., Moore B.E., Nakajima T., Scholl D., Schaid D.J., Weyand C.M., et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 193 10 (2001) 1159-1167
88. Nakajima T., Goek O., Zhang X., Kopecky S.L., Frye R.L., Goronzy J.J., et al. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res 93 2 (2003) 106-113
89. Majorczyk E., Pawlik A., Luszczek W., Nowak I., Wisniewski A., Jasek M., et al. Associations of killer cell immunoglobulin-like receptor genes with complications of rheumatoid arthritis. Genes Immun 8 8 (2007) 678-683
90. Momot T., Koch S., Hunzelmann N., Krieg T., Ulbricht K., Schmidt R.E., et al. Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum 50 5 (2004) 1561-1565
91. Suzuki Y., Hamamoto Y., Ogasawara Y., Ishikawa K., Yoshikawa Y., Sasazuki T., et al. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. J Invest Dermatol 122 5 (2004) 1133-1136
92. Luszczek W., Manczak M., Cislo M., Nockowski P., Wisniewski A., Jasek M., et al. Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. Hum Immunol 65 7 (2004) 758-766
93. Holm S.J., Sakuraba K., Mallbris L., Wolk K., Stahle M., and Sanchez F.O. Distinct HLA-C/KIR genotype profile associates with guttate psoriasis. J Invest Dermatol 125 4 (2005) 721-730
94. Nelson G.W., Martin M.P., Gladman D., Wade J., Trowsdale J., and Carrington M. Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J Immunol 173 7 (2004) 4273-4276
95. Kitawaki J., Xu B., Ishihara H., Fukui M., Hasegawa G., Nakamura N., et al. Association of killer cell immunoglobulin-like receptor genotypes with susceptibility to endometriosis. Am J Reprod Immunol 58 6 (2007) 481-486
96. Levinson R.D., Du Z., Luo L., Monnet D., Tabary T., Brezin A.P., et al. Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals. Genes Immun (2008)
97. Boyton R.J., Smith J., Ward R., Jones M., Ozerovitch L., Wilson R., et al. HLA-C and killer cell immunoglobulin-like receptor genes in idiopathic bronchiectasis. Am J Respir Crit Care Med 173 3 (2006) 327-333
98. Karlsen T.H., Boberg K.M., Olsson M., Sun J.Y., Senitzer D., Bergquist A., et al. Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis. J Hepatol 46 5 (2007) 899-906
99. van der Slik A.R., Koeleman B.P., Verduijn W., Bruining G.J., Roep B.O., and Giphart M.J. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 52 10 (2003) 2639-2642
100. Middleton D., Halfpenny I., Meenagh A., Williams F., Sivula J., and Tuomilehto-Wolf E. Investigation of KIR gene frequencies in type 1 diabetes mellitus. Hum Immunol 67 12 (2006) 986-990
101. Naumova E., Mihaylova A., Stoitchkov K., Ivanova M., Quin L., and Toneva M. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals. Cancer Immunol Immunother 54 2 (2005) 172-178
102. Naumova E., Mihaylova A., Ivanova M., and Mihailova S. Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma. Cancer Immunol Immunother 56 1 (2007) 95-100
103. Verheyden S., Bernier M., and Demanet C. Identification of natural killer cell receptor phenotypes associated with leukaemia. Leukemia 18 12 (2004) 2002-2007
104. Gati A., Da Rocha S., Guerra N., Escudier B., Moretta A., Chouaib S., et al. Analysis of the natural killer mediated immune response in metastatic renal cell carcinoma patients. Int J Cancer 109 3 (2004) 393-401
105. Scquizzato E., Teramo A., Miorin M., Facco M., Piazza F., Noventa F., et al. Genotypic evaluation of killer immunoglobulin-like receptors in NK-type lymphoproliferative disease of granular lymphocytes. Leukemia 21 5 (2007) 1060-1069
106. Besson C., Roetynck S., Williams F., Orsi L., Amiel C., Lependeven C., et al. Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study. PLoS One 2 5 (2007) e406
107. Carrington M., Wang S., Martin M.P., Gao X., Schiffman M., Cheng J., et al. Hierarchy of resistance to cervical neoplasia mediated by combinations of killer immunoglobulin-like receptor and human leukocyte antigen loci. J Exp Med 201 7 (2005) 1069-1075
108. Butsch Kovacic M., Martin M., Gao X., Fuksenko T., Chen C.J., Cheng Y.J., et al. Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 14 11 Pt 1 (2005) 2673-2677
109. Lopez-Vazquez A., Rodrigo L., Martinez-Borra J., Perez R., Rodriguez M., Fdez-Morera J.L., et al. Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection. J Infect Dis 192 1 (2005) 162-165
110. Bahler D.W., Hartung L., Hill S., Bowen G.M., and Vonderheid E.C. CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sezary syndrome by flow cytometry. Cytometry B Clin Cytom 74B 3 (2007) 156-162
111. Morice W.G., Kurtin P.J., Leibson P.J., Tefferi A., and Hanson C.A. Demonstration of aberrant T-cell and natural killer-cell antigen expression in all cases of granular lymphocytic leukaemia. Br J Haematol 120 6 (2003) 1026-1036
112. Nowakowski G.S., Morice W.G., Phyliky R.L., Li C.Y., and Tefferi A. Human leucocyte antigen class I and killer immunoglobulin-like receptor expression patterns in T-cell large granular lymphocyte leukaemia. Br J Haematol 128 4 (2005) 490-492
113. Zambello R., Falco M., Della Chiesa M., Trentin L., Carollo D., Castriconi R., et al. Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes. Blood 102 5 (2003) 1797-1805
114. Moffett A., and Hiby S.E. How Does the maternal immune system contribute to the development of pre-eclampsia?. Placenta 28 Suppl A (2007) S51-S56
115. Hanna J., Goldman-Wohl D., Hamani Y., Avraham I., Greenfield C., Natanson-Yaron S., et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat Med 12 9 (2006) 1065-1074
116. Trundley A., and Moffett A. Human uterine leukocytes and pregnancy. Tissue Antigens 63 1 (2004) 1-12
117. Hiby S.E., Walker J.J., O'Shaughnessy K.M., Redman C.W., Carrington M., Trowsdale J., et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med 200 8 (2004) 957-965
118. Paparistidis N., Papadopoulou C., Chioti A., Papaioannou D., Tsekoura C., Keramitsoglou T., et al. How valuable is measurement of peripheral blood natural killer cells at the time of abortion?. Am J Reprod Immunol 59 4 (2008) 306-315
119. Varla-Leftherioti M., Spyropoulou-Vlachou M., Keramitsoglou T., Papadimitropoulos M., Tsekoura C., Graphou O., et al. Lack of the appropriate natural killer cell inhibitory receptors in women with spontaneous abortion. Hum Immunol 66 1 (2005) 65-71
120. Hiby S.E., Regan L., Lo W., Farrell L., Carrington M., and Moffett A. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod 23 4 (2008) 972-976
121. Wang S., Zhao Y.R., Jiao Y.L., Wang L.C., Li J.F., Cui B., et al. Increased activating killer immunoglobulin-like receptor genes and decreased specific HLA-C alleles in couples with recurrent spontaneous abortion. Biochem Biophys Res Commun 360 3 (2007) 696-701
122. Yan W.H., Lin A., Chen B.G., Zhou M.Y., Dai M.Z., Chen X.J., et al. Possible roles of KIR2DL4 expression on uNK cells in human pregnancy. Am J Reprod Immunol 57 4 (2007) 233-242
123. Witt C.S., Whiteway J.M., Warren H.S., Barden A., Rogers M., Martin A., et al. Alleles of the KIR2DL4 receptor and their lack of association with pre-eclampsia. Eur J Immunol 32 1 (2002) 18-29
124. Witt C.S., Goodridge J., Gerbase-Delima M.G., Daher S., and Christiansen F.T. Maternal KIR repertoire is not associated with recurrent spontaneous abortion. Hum Reprod 19 11 (2004) 2653-2657
125. Martin M.P., Nelson G., Lee J.H., Pellett F., Gao X., Wade J., et al. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol 169 6 (2002) 2818-2822